Mid-urethral slings in female incontinence: Current status

• Published in: Indian journal of urology Vol. 27; no. 3; pp. 320 - 325
• Main Authors: Krlin, Ryan M, Murphy, Alana M, Ingber, Michael S, Vasavada, Sandip P
• Format: Journal Article
• Language: English
• Published: India Medknow Publications and Media Pvt. Ltd 01-07-2011; Medknow Publications & Media Pvt. Ltd; Medknow Publications; Wolters Kluwer Medknow Publications
• Subjects: Care and treatment; Cost control; Incontinence surgery; mid-urethral sling; Obesity; Review; Stent (Surgery); stress urinary incontinence; tension-free vaginal tape; transobturator tape; Urinary incontinence; India; mid-urethral sling; Incontinence surgery; tension-free vaginal tape; transobturator tape; stress urinary incontinence
• ISSN: 0970-1591; 1998-3824
• DOI: 10.4103/0970-1591.85424

The advent of the mid-urethral sling (MUS) 15 years ago has drastically changed the surgical management of stress urinary incontinence (SUI). Both retropubic and transobturator MUS can be placed in the ambulatory setting with excellent results. The tension-free vaginal tape (TVT) sling has the most robust and long-term data, but more recent literature suggests that the transobturator tape sling may offer comparable efficacy in appropriately selected patients. Single incision sling (SIS) is the newest addition to the MUS group and was developed in an attempt to minimize morbidity and create an anti-incontinence procedure that could be performed in the office. The efficacy of SIS remains unknown as the current literature regarding SIS lacks long-term results and comparative trials. The suprapubic arc sling appears to have equally effective outcomes in at least the short-term when compared with TVT. Although evolution of the SIS has led to a less invasive procedure with decreased post-op pain and reduced recovery time, durability of efficacy could be the endpoint we are sacrificing. Until longer-term data and more quality comparison trials are available, tailoring one's choice of MUS to the individual patient and her unique clinical parameters remains the best option.